Have an account? Log in to check out faster.
Prescription medications are provided as part of a holistic health approach - alongside lifestyle, nutrition and wellbeing support - so you make sustainable, confident progress.
Individual clinical assessment
Treatment options explained clearly
Dose and side-effect support
Longer-term maintenance planning
Injection and tablet options include Mounjaro, Wegovy and Foundayo, where clinically appropriate.
No treatment is guaranteed before review
GPhC registration 9012993
Available to eligible adults of all genders
Progress, safety and maintenance are reviewed
How LIVVE works
Tell LIVVE about your health, medicines, weight history, previous treatment and goals.
Discuss suitability, expectations, treatment preferences and whether further checks are needed.
Your clinician explains appropriate options, dosing, costs, monitoring and next steps.
Review progress, side effects, nutrition, dose suitability and longer-term plans.
Treatment information
These pages explain how each treatment works, including dosing, safety and support. Not every treatment is suitable for everyone, and your clinician will recommend options based on your individual assessment.
Once-weekly injection
Tirzepatide acts on GIP and GLP-1 receptors.
Price From £205.00
for the listed lowest dose
Once-weekly injection
Semaglutide acts on the GLP-1 receptor.
Price From £185.00
for the listed lowest dose
Once-daily tablet
Wegovy tablets contain semaglutide and are taken once daily.
Price From £99.00
first month
Once-daily tablet
Foundayo tablets contain orforglipron and are taken once daily.
Price From £99.00
first month
About treatment prices
Prices shown are based on the listed starting dose and may change if your prescribed dose changes. Treatment is supplied following clinical assessment.
Ongoing clinical support
LIVVE supports you before, during and beyond prescribing. Your plan can be reviewed as your health, response, routine and goals change.
A real LIVVE experience
Alison’s life-changing hormone & weight loss journey
Hear how expert support, HRT and Mounjaro transformed Alison’s health and quality of life.
Patient reviews
Patients consistently highlight feeling listened to, supported and clearly guided throughout their care with LIVVE.
Such a refreshing experience.
Melissa really listened to my symptoms, and took time to understand.
I wish every health appointment was like this!
Melissa is extremely helpful, never rushes through the appointment.
Who may be suitable
Your weight, health risks, medicines, previous approaches and treatment preferences all matter. BMI may form part of the assessment but should not be treated as the only deciding factor.
Why choose LIVVE
LIVVE looks at weight management within the wider context of your health, symptoms, medicines and stage of life.
Weight changes are considered alongside menopause symptoms and changes in body composition.
HRT and other medicines can be reviewed together as part of your wider clinical picture.
Assessment, prescribing and ongoing support are provided through a regulated clinical service.
Blood testing is available where it may be clinically helpful to guide care or investigate symptoms.
Treatment choices may include injection and tablet options, depending on clinical suitability.
The focus extends beyond initial prescribing to progress, maintenance and sustainable next steps.
Start with a clinical assessment and find out what support may be appropriate for your health, routine and goals.
This page provides general information and does not replace individual medical advice. Mounjaro and Wegovy are prescription-only medicines supplied only after assessment and approval by an appropriate prescriber. Prescription weight-management medicines are intended for people who meet clinical criteria and are not prescribed for cosmetic weight loss. Reading a treatment page or completing an assessment does not guarantee prescribing. Final pricing, service inclusions, links and clinical wording should be confirmed before publication.
